Jackie Brown joined Rx Communications as a HEOR consultant in October this year. She has 18 years of pharma experience, both at the regional and global level. She was until recently an Associate Vice President in Health Outcomes at Eli Lilly and Company. She brings with her a wealth of knowledge in drug development and the commercialization process. She has published extensively demonstrating her expertise in real-world data and economic modelling. Her particular therapeutic area of interest is in oncology but also has also experience in other therapeutic area. Jackie worked in academia for over 16 year prior to joining pharma and has an MSc and PhD in health economics.
10 things to be successful in Health Economics Health economics, as applied in the pharmaceutical industry (also commonly referred to as pharmacoeconomics), is concerned with providing evidence to demonstrate the…
WOW! What a buzz around Real Word Evidence (RWE)! I don’t think I have ever heard so much enthusiasm and expression of need for RWE and collaboration between European (EU)…
What to watch out for at ISPOR Europe 2022 This year the theme for the ISPOR European conference to be held in Vienna, 6-9 November is Collaborating Across Boarders:…